HNN3.0
Register
Register
Register

Project cooperationUpdated on 19 October 2026

Disrupting Gram Negative bacterial biofilms

Chief Scientific Officer at Biophys Limited

Cardiff, United Kingdom

About

We would like to partner with developers of novel antimicrobial agents against priority Gram-negative bacteria to develop co-therapies that can be administered orally, by IV or IP.

We are a small organisation and cannot lead such a project, but we can provide small-molecule scaffolds and conduct antibiofilm and cytotoxicity research in our own BSL Class 2 facilities.

Topic

  • Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Organisation

Biophys Limited

Company (SME)

Cardiff, United Kingdom

Similar opportunities